Finance entity
earnings is the sole category represented across all 1 tracked stories. Damien Leonard is most often covered alongside ImmuCell, which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.2 in the same window.
Last mentioned: Mar 4, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
earnings is the sole category represented across all 1 tracked stories. Damien Leonard is most often covered alongside ImmuCell, which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.2 in the same window. Each story carries 2 original sources on average, compared with 2.6 for the broader beat in this window. Damien Leonard appears in 1 tracked Finance story from March 4, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 74 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Damien Leonard. Shared-story counts are live from our verified record — not editorial picks.
ImmuCell (ICCC) has issued its preliminary 2025 financial results, highlighting a year of operational scaling for its bovine immunity products. Simultaneously, major shareholder Pinetree Capital Ltd released audited figures and expanded its board, signaling a period of strategic consolidation for the animal health biotech and its primary backer.
Damien Leonard is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
